LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
Hs 578T Lapatinib
10
uM
LJP6
0.6530 0.0929 0.6357 0.0781
Hs 578T Sirolimus
0.04
uM
LJP6
0.6552 0.0324 0.6292 0.0511
Hs 578T Sirolimus
0.12
uM
LJP6
0.6443 0.0237 0.6193 0.0276
Hs 578T Sirolimus
0.37
uM
LJP6
0.6452 0.0183 0.6193 0.0318
Hs 578T Sirolimus
1.11
uM
LJP6
0.6554 0.0334 0.6321 0.0417
Hs 578T Sirolimus
3.33
uM
LJP6
0.6461 0.0292 0.6210 0.0381
Hs 578T Sirolimus
10
uM
LJP6
0.6457 0.0390 0.6196 0.0518
Hs 578T ZSTK474
0.04
uM
LJP6
0.8080 0.0097 0.8057 0.0099
Hs 578T ZSTK474
0.12
uM
LJP6
0.6808 0.0115 0.6629 0.0187
Hs 578T ZSTK474
0.37
uM
LJP6
0.5693 0.0129 0.5221 0.0509
Hs 578T ZSTK474
1.11
uM
LJP6
0.4755 0.0265 0.3943 0.0702
Hs 578T ZSTK474
3.33
uM
LJP6
0.4018 0.0296 0.2889 0.0581
Hs 578T ZSTK474
10
uM
LJP6
0.3161 0.0389 0.1477 0.0630
Hs 578T BX-912
0.04
uM
LJP5
0.9636 0.0165 0.9673 0.0119
Hs 578T BX-912
0.12
uM
LJP5
0.8982 0.0380 0.9062 0.0262
Hs 578T BX-912
0.37
uM
LJP5
0.7517 0.1075 0.7557 0.0922
Hs 578T BX-912
1.11
uM
LJP5
0.4517 0.0543 0.3749 0.0244
Hs 578T BX-912
3.33
uM
LJP5
0.3088 0.0577 0.1432 0.0436
Hs 578T BX-912
10
uM
LJP5
0.1887 0.0502 -0.1029 0.0796
Hs 578T Selumetinib
0.04
uM
LJP6
0.6632 0.0194 0.6363 0.0543
Hs 578T Selumetinib
0.12
uM
LJP6
0.5772 0.0173 0.5304 0.0593
Hs 578T Selumetinib
0.37
uM
LJP6
0.5284 0.0080 0.4708 0.0392
Hs 578T Selumetinib
1.11
uM
LJP6
0.4955 0.0176 0.4276 0.0316
Hs 578T Selumetinib
3.33
uM
LJP6
0.4533 0.0312 0.3692 0.0207
Hs 578T Selumetinib
10
uM
LJP6
0.3817 0.0434 0.2604 0.0324